- Drug Pipelines
- April 2025
- 40 Pages
Global
From €1118EUR$1,250USD£964GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1789EUR$2,000USD£1,543GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1341EUR$1,500USD£1,157GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3354EUR$3,750USD£2,893GBP
- Report
- September 2024
- 80 Pages
Japan
From €3130EUR$3,500USD£2,700GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2683EUR$3,000USD£2,314GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1789EUR$2,000USD£1,543GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1341EUR$1,500USD£1,157GBP
- Report
- June 2024
- 200 Pages
Global
From €7110EUR$7,950USD£6,133GBP
- Report
- March 2024
- 120 Pages
Global
From €7110EUR$7,950USD£6,133GBP
- Report
- November 2023
- 30 Pages
Global
From €2906EUR$3,250USD£2,507GBP
- Report
- May 2023
- 160 Pages
Global
From €4426EUR$4,949USD£3,818GBP
- Report
- April 2023
- 147 Pages
Global
From €4426EUR$4,949USD£3,818GBP
- Report
- May 2024
- 133 Pages
Global
From €3576EUR$3,999USD£3,085GBP
- Report
- May 2024
- 136 Pages
Global
From €3576EUR$3,999USD£3,085GBP
- Report
- April 2023
- 115 Pages
Global
From €4248EUR$4,750USD£3,664GBP
- Report
- January 2022
- 115 Pages
Global
From €4248EUR$4,750USD£3,664GBP
- Report
- January 2025
- 144 Pages
Global
From €3532EUR$3,950USD£3,047GBP
- Report
- December 2022
- 72 Pages
Global
From €3126EUR$3,495USD£2,696GBP
- Report
- May 2023
- 215 Pages
Global
From €3219EUR$3,600USD£2,777GBP

The Influenza Drug market is a subset of the larger Respiratory Drug market, which includes treatments for a variety of respiratory illnesses, such as asthma, COPD, and cystic fibrosis. Influenza drugs are used to treat the symptoms of the flu, such as fever, cough, and sore throat. These drugs can also help reduce the risk of complications from the flu, such as pneumonia. Commonly used influenza drugs include antivirals, such as oseltamivir and zanamivir, and anti-inflammatory drugs, such as ibuprofen and acetaminophen.
Some companies in the Influenza Drug market include GlaxoSmithKline, Sanofi, Novartis, and AstraZeneca. Other companies include Roche, Merck, and Pfizer. Show Less Read more